Increased frequency of the C3*F allele and the Leiden mutation of coagulation factor V in patients with severe coronary heart disease who survived myocardial infarction

Experimental and Clinical Immunogenetics

Volumn 18, Issue 4, 2001, Pages 206-212

  Császár, Albert ^a   Duba, Jenõ ^b   Melegh, Béla ^c   Kramer, Judith ^d   Szalai, Csaba ^e   Prohászka, Zoltán ^a,f   Karádi, István ^a,f   Kovács, Margit ^a,f   Méhes, Károly ^c   Romics, László ^a,f   Füst, George ^a,f  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b National Institute of Cardiology Budapest   (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

^d ST JOHN'S HOSPITAL   (Hungary)

^e Heim Pál Childre's Hospital   (Hungary)

^f INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

C3; Complement; Coronary heart disease; Factor V; Leiden mutation; Myocardial infarction

Indexed keywords

BLOOD CLOTTING FACTOR 5; COMPLEMENT COMPONENT C3;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; ELECTROPHORESIS; FEMALE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; COMPLEMENT C3; CORONARY DISEASE; FACTOR V; FEMALE; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; MUTATION; MYOCARDIAL INFARCTION; RISK FACTORS;

EID: 18344397120     PISSN: 02549670     EISSN: None     Source Type: Journal    
DOI: 10.1159/000049199     Document Type: Article

References (30)

1. Insight into the genetic epidemiology of coronary heart disease
2. Hypercoagulability in venous and arterial thrombosis
3. Arg506GIn factor V mutation (factor V Leiden) in patients with ischemic cerebrovascular disease and survivors of myocardial infarction
4. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women
5. Arterial and venous thromboembolism with fatal outcome and resistance to activated protein C
6. Myocardial infarction associated with homozygous resistance to activated protein C
7. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men
8. Premature ischaemic heart disease and the gene for coagulation factor V
9. Factor V Leiden in patients with acute coronary syndromes
10. Molecular basis of human complement component C3
11. Complement C4, factor B and C3 polymorphism in North India
12. Complement C2, C3, C4 and factor B allele distribution in the Gipsy population in Hungary
13. The complement C3F gene as a risk factor for vascular events in hypertension
14. C3 polymorphism in relation to age
15. A hypothesis on the development of acute myocardial infarction in Greenlanders
16. Potential markers of the atherosclerotic process in high-risk children
17. Apolipoprotein E and complement C3 polymorphism and their role in the response to gemfibrozil and low fat low cholesterol therapy
18. Association of genetic markers with coronary heart disease (myocardial infarction) - A case-control study
19. Selective coronary angiography: I. Percutaneous transfemoral approach
20. High voltage agarose electrophoresis in the study of C3 polymorphism
21. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis
22. Vulnerable plaque: Pathobiology and clinical implications
23. Atherosclerosis - An inflammatory disease
24. Functional consequences of the genetic polymorphism of the third component of complement
25. Polymorphism of complement C3 in chronic inflammatory bowel disease. Predominance of the C3F gene in Crohn's disease
26. GC and C3 serum groups in ulcerative colitis
27. Molecular analysis of C3 allotypes related to transplant outcome in human renal allografts
28. Association between coronary heart disease and C3F-gene in essential hypertension
29. Molecular analysis of C3 allotypes in patients with systemic vasculitis
30. The C3-F gene in patients with intracranial saccular aneurysms